secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001356576-24-000006
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus announces Feb 27 earnings release date for Q4 and FY 2023
------------------------------------------------------------------

- Earnings release for Q4 and full year 2023 expected after market close on February 27, 2024.
- Conference call at 4:30 PM ET on Feb 27 with CEO Jack Khattar and CFO Tim Dec.
- No preliminary financial results disclosed; only schedule details provided in this filing.
- Webcast and replay available on investor relations website for 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000006/0001356576-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000006/supn-20240213.htm
  HTML page:      https://secwatch.observer/filing/0001356576-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer